BVF PARTNERS L PIL Net Worth - Insider Trades and Bio as of Jun 18, 2026

Repare Therapeutics Inc.SEC CIK: 0001055947

Estimated Net Worth

$4.34 Billion

Last Updated: May 19, 2026 11:07 PM EST

Transaction Summary

Total Transactions471

Buy-Sell Ratio2.88

Buy Transactions242

Sell Transactions84

Transaction Volume

Total Volume-$458.79M

Net Volume$1.78B

Buy Volume$658.82M

Sell Volume-$1.12B

Trade Analysis

AVG Trade Size-$1.08M

Largest Trade$25.58M

Most Active MonthNov

Most Active Year2008

Trading Sentiment

OverallBullish

Recent TradeSelling

Last 90 Days-1 Trades

ConvictionMedium

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Partners L P/il Bvf has an estimated net worth of $4.34 Billion. This is based on reported shares across multiple companies, which include Allakos Inc., Rain Oncology Inc., ARENA PHARMACEUTICALS INC, IMMUNE DESIGN CORP., Cascadian Therapeutics, Inc., Capstone Therapeutics Corp., ChemoCentryx, Inc., DYNAVAX TECHNOLOGIES CORP, REPLIGEN CORP, KENT INTERNATIONAL HOLDINGS INC, NEUROCRINE BIOSCIENCES INC, XOMA Royalty Corp, LIGAND PHARMACEUTICALS INC, RIGEL PHARMACEUTICALS INC, Xenon Pharmaceuticals Inc., Cullinan Oncology, Inc., Merus N.V., Nivalis Therapeutics, Inc., Repare Therapeutics Inc., PALVELLA THERAPEUTICS, INC., Verastem, Inc., Syndax Pharmaceuticals Inc, CTI BIOPHARMA CORP, IDEAYA Biosciences, Inc., CYTOKINETICS INC, Kymera Therapeutics, Inc., CURIS INC, Calithera Biosciences, Inc., CONCERT PHARMACEUTICALS, INC., PALATIN TECHNOLOGIES INC, MEDICINOVA INC, CATALYST BIOSCIENCES, INC., CytomX Therapeutics, Inc., MoonLake Immunotherapeutics, GLYCOMIMETICS INC, Principia Biopharma Inc., INFINITY PHARMACEUTICALS, INC., Eledon Pharmaceuticals, Inc., Olema Pharmaceuticals, Inc., Regulus Therapeutics Inc., ADVANCED MAGNETICS INC, ESSA Pharma Inc., 4D Molecular Therapeutics, Inc., NPS PHARMACEUTICALS INC, ICAGEN INC, ADOLOR CORP, Third Harmonic Bio, Inc., ZONAGEN INC, COMBINATORX, INC, Regado Biosciences Inc, SUPERGEN INC, FIVE PRIME THERAPEUTICS, INC., Structure Therapeutics Inc., ARRAY BIOPHARMA INC, ARQULE INC, AEOLUS PHARMACEUTICALS, INC., INHIBITEX, INC., NEUROBIOLOGICAL TECHNOLOGIES INC /CA/, enGene Holdings Inc., Celera CORP, FACET BIOTECH CORP, PHARMACOPEIA INC, AVIGEN INC \DE, SGX PHARMACEUTICALS, INC., VIACELL INC, NEUROGEN CORP, POINT Biopharma Global Inc., GENAERA CORP, AEROGEN INC, CORVAS INTERNATIONAL INC, BIOCRYST PHARMACEUTICALS INC, APPLIED MOLECULAR EVOLUTION INC, and IMMUNIC, INC..

2008 was Partners L P/il Bvf's most active year for acquiring shares with 351 total transactions. Partners L P/il Bvf's most active month to acquire stocks was the month of October. 2009 was Partners L P/il Bvf's most active year for disposing of shares, totalling 86 transactions. Partners L P/il Bvf's most active month to dispose stocks was the month of December. 2021 saw Partners L P/il Bvf paying a total of $132,144,944.64 for 12,405,370 shares, this is the most they've acquired in one year. In 2023 Partners L P/il Bvf cashed out on 40,301,603 shares for a total of $294,248,967.10, their largest year based on trade value.

Holdings & Transactions

RPTXrepare therapeutics inc.

Updated: Jan 30, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	10.17M	—	—	Jan 30, 2026	—	Disposition	—	Jan 28	View
From 4	0.07	1.23M	$5.19	$6.25M	Nov 17, 2023	20.04M	Purchase	—	Nov 15 - 16	View
From 4	0.10	783.71K	$3.60	$2.82M	Nov 03, 2023	8.94M	Purchase	—	Nov 02	View
From 4	0.02	149.16K	$12.73	$1.90M	Jun 15, 2022	8.16M	Purchase	—	Jun 13	View
From 4	0.30	1.84M	$11.90	$21.86M	Jun 06, 2022	8.01M	Purchase	—	Jun 02 - 06	View
From 4	0.07	420.00K	$8.50	$3.57M	May 20, 2022	6.17M	Purchase	—	May 18	View
From 4	0.21	997.96K	$14.10	$14.07M	Jan 21, 2022	5.75M	Purchase	—	Jan 19	View
From 3	—	—	—	—	Nov 08, 2021	4.75M	—	—	—	View

MLTXmoonlake immunotherapeutics

Updated: Apr 02, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.19	3.75M	$16.79	-$62.96M	Apr 02, 2026	15.97M	Sale	—	Mar 31	View
From 4	—	6.68K	—	—	Jun 09, 2025	19.72M	Grant	—	Jun 05	View
From 4	-0.09	2.00M	$50.00	-$100.00M	Oct 08, 2024	19.71M	Sale	—	Oct 04	View
From 4	—	7.69K	—	—	Jun 10, 2024	21.71M	Grant	—	Jun 06	View
From 4	—	11.30K	—	—	Jun 12, 2023	21.70M	Grant	—	Jun 08	View
From 3	—	—	—	—	Apr 15, 2022	21.69M	—	—	—	View

IMUXimmunic, inc.

Updated: Feb 27, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Feb 27, 2026	7.59M	—	—	—	View

allakos inc.

Updated: May 19, 2025

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	16.31M	—	—	May 19, 2025	—	Disposition	—	May 15	View
From 3	—	—	—	—	Jan 26, 2024	16.31M	—	—	—	View

XOMAxoma royalty corp

Updated: May 20, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.13	392.72K	$27.10	-$10.64M	May 20, 2025	2.60M	Sale	—	May 16	View
From 4	-0.18	650.72K	$26.10	-$16.98M	Jan 28, 2025	2.99M	Sale	—	Jan 24	View
From 4	—	10.97K	—	—	May 19, 2023	3.91M	Grant	—	May 17	View
From 4	0.01	22.25K	$19.15	$420.74K	Jan 09, 2023	3.90M	Purchase	—	Jan 05 - 06	View
From 4	0.01	24.64K	$16.61	$409.31K	Sep 27, 2022	3.88M	Purchase	—	Sep 23 - 27	View
From 4	0.02	56.31K	$17.70	$990.72K	Sep 16, 2022	3.85M	Purchase	—	Sep 14 - 16	View
From 4	—	9.00K	—	—	May 20, 2022	3.80M	Grant	—	May 18	View
From 4	—	5.10K	—	—	May 21, 2021	3.79M	Grant	—	May 19	View
From 4	-0.16	651.70K	$38.36	-$25.00M	Apr 02, 2021	3.78M	Sale	—	Mar 31	View
From 4	—	200.00K	$25.00	$5.00M	Dec 15, 2020	4.43M	Purchase	—	Dec 11	View
From 4	0.01	51.37K	$18.34	$941.96K	Sep 23, 2020	4.23M	Purchase	—	Sep 21 - 23	View
From 4	0.00	7.74K	$18.77	$145.23K	Sep 10, 2020	4.18M	Purchase	—	Sep 04	View
From 4	0.01	35.62K	$18.71	$666.48K	Sep 01, 2020	4.16M	Purchase	—	Aug 28 - 01	View
From 4	0.01	28.18K	$19.41	$546.65K	Aug 25, 2020	4.13M	Purchase	—	Aug 21 - 25	View
From 4	0.00	6.16K	$19.47	$120.00K	Aug 20, 2020	4.06M	Purchase	—	Aug 18 - 20	View
From 4	0.01	27.02K	$18.46	$498.74K	Aug 14, 2020	4.06M	Purchase	—	Aug 12 - 14	View
From 4	0.53	1.25M	$13.00	$16.29M	Apr 17, 2020	4.03M	Options	—	Apr 15	View
From 4	0.01	8.26K	$17.20	$142.13K	Mar 27, 2020	2.78M	Purchase	—	Mar 25	View
From 4	0.00	4.44K	$14.52	$64.47K	Mar 20, 2020	2.77M	Purchase	—	Mar 18	View
From 4	0.10	118.28K	$17.94	$2.12M	Mar 17, 2020	2.77M	Purchase	—	Mar 13 - 17	View
From 4	0.10	373.19K	$22.00	$18.60M	Dec 20, 2019	4.53M	Purchase	—	Dec 18 - 19	View
From 4	0.04	27.91K	$14.63	$408.23K	May 14, 2019	1.80M	Purchase	—	May 10 - 14	View
From 4	0.04	25.68K	$28.63	$406.79K	Dec 19, 2018	1.78M	Purchase	—	Dec 14 - 18	View
From 4	0.06	36.46K	$14.46	$527.24K	Dec 13, 2018	1.75M	Purchase	—	Dec 11 - 13	View
From 4	0.10	61.02K	$14.71	$897.45K	Dec 10, 2018	1.71M	Purchase	—	Dec 06 - 10	View
From 4	0.02	9.80K	$14.91	$146.14K	Dec 04, 2018	1.65M	Purchase	—	Nov 30 - 04	View
From 4	0.05	29.70K	$15.10	$448.48K	Nov 29, 2018	1.64M	Purchase	—	Nov 27 - 29	View
From 4	0.15	72.25K	$14.17	$1.02M	Nov 21, 2018	1.61M	Purchase	—	Nov 19 - 21	View
From 4	0.07	31.99K	$13.48	$431.35K	Nov 19, 2018	1.54M	Purchase	—	Nov 15 - 16	View
From 3	—	—	—	—	Feb 21, 2017	1.50M	—	—	—	View

KYMRkymera therapeutics, inc.

Updated: Jul 01, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.07	333.17K	$44.00	$13.96M	Jul 01, 2025	6.83M	Purchase	—	Jun 25 - 30	View
From 4	—	358.29K	$40.75	$14.60M	Aug 22, 2024	6.49M	Purchase	—	Aug 20	View
From 4	—	16.00K	—	—	Jun 28, 2024	6.13M	Grant	—	Jun 18	View
From 4	—	979.01K	$25.25	$24.72M	Jan 09, 2024	6.12M	Purchase	—	Jan 05	View
From 4	0.04	414.11K	$12.85	$5.30M	Nov 06, 2023	10.00M	Purchase	—	Nov 02 - 03	View
From 4	—	12.00K	—	—	Jun 20, 2023	4.72M	Grant	—	Jun 15	View
From 4	0.00	41.01K	$30.57	$1.25M	Jan 13, 2023	9.08M	Purchase	—	Jan 11 - 12	View
From 4	0.13	545.52K	$26.00	$14.18M	Aug 23, 2022	4.67M	Purchase	—	Aug 22	View
From 4	—	12.00K	—	—	Jun 17, 2022	4.13M	Grant	—	Jun 15	View
From 4	0.08	289.43K	$14.34	$4.15M	May 31, 2022	4.11M	Purchase	—	May 26 - 27	View
From 4	0.00	10.10K	$14.00	$141.39K	May 24, 2022	3.83M	Purchase	—	May 20	View
From 4	0.07	250.00K	$19.45	$4.87M	May 09, 2022	3.81M	Purchase	—	May 05 - 06	View
From 4	0.04	130.31K	$38.96	$5.08M	Jan 31, 2022	3.56M	Purchase	—	Jan 27 - 31	View
From 4	0.09	272.77K	$37.76	$10.30M	Jan 26, 2022	3.43M	Purchase	—	Jan 24	View
From 4	0.21	544.17K	$47.00	$25.58M	Jul 06, 2021	3.16M	Purchase	—	Jul 01	View
From 4	—	20.06K	—	—	Jun 21, 2021	2.62M	Grant	—	Jun 16	View
From 4	-0.00	661.00	$20.00	—	Aug 25, 2020	2.60M	Options	—	Aug 20 - 21	View
From 3	—	—	—	—	Aug 25, 2020	—	—	—	—	View

CBIOglycomimetics inc

Updated: Jun 17, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	19.92	1.86M	—	—	Jun 17, 2025	1.95M	Acquisition	—	Jun 13	View
From 4	0.16	1.27M	$2.60	$3.29M	Nov 06, 2020	9.32M	Purchase	—	Nov 04	View
From 4	0.13	932.61K	$2.75	$2.56M	Nov 03, 2020	8.06M	Purchase	—	Oct 30	View
From 4	0.31	1.67M	$3.18	$5.31M	Sep 09, 2019	7.12M	Purchase	—	Sep 05	View
From 3	—	—	—	—	Aug 26, 2019	5.46M	—	—	—	View
From 3	—	—	—	—	May 11, 2017	3.02M	—	—	—	View

OLMAolema pharmaceuticals, inc.

Updated: Jun 13, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	24.15K	—	—	Jun 13, 2025	11.54M	Grant	—	Jun 11	View
From 4	—	—	—	—	Jan 14, 2025	11.51M	Acq/Dis	—	Jan 10	View
From 4	0.20	2.47M	$9.08	$22.38M	Dec 04, 2024	14.88M	Acquisition	—	Dec 04	View
From 4	—	23.00K	—	—	Jun 18, 2024	9.05M	Grant	—	Jun 14	View
From 4	0.22	1.61M	$9.84	$14.82M	Sep 14, 2023	9.03M	Purchase	—	Sep 12 - 14	View
From 4	—	21.52K	—	—	Jun 21, 2023	7.42M	Grant	—	Jun 16	View
From 4	0.03	200.00K	$4.03	$806.90K	Jun 14, 2022	7.38M	Purchase	—	Jun 10	View
From 4	0.12	739.67K	$9.39	$6.95M	Dec 02, 2021	7.18M	Purchase	—	Nov 30	View
From 4	—	99.56K	—	—	May 26, 2021	6.52M	Acq/Dis	—	Mar 31	View
From 4	0.23	1.20M	$19.00	—	Nov 20, 2020	6.42M	Purchase	—	Nov 18 - 19	View
From 3	—	—	—	—	Nov 19, 2020	—	—	—	—	View

EPIXessa pharma inc.

Updated: Oct 14, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	11.48M	—	—	Oct 14, 2025	—	Disposition	—	Oct 09	View
From 4	-0.00	156.00	$1.88	-$0.96	Aug 07, 2025	22.96M	Sale	—	Aug 05	View
From 3	—	—	—	—	Jul 21, 2022	8.56M	—	—	—	View

RAINrain oncology inc.

Updated: Jan 29, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	8.63M	—	—	Jan 29, 2024	—	Disposition	—	Jan 25 - 26	View
From 4	0.48	1.71M	$5.83	$9.97M	Nov 10, 2022	8.60M	Purchase	—	Nov 08	View
From 4	0.20	557.73K	$12.00	$6.69M	Jan 10, 2022	6.87M	Purchase	—	Jan 06 - 07	View
From 4	0.00	11.03K	$13.94	$153.83K	Sep 23, 2021	6.31M	Purchase	—	Sep 21	View
From 4	0.17	392.27K	$16.49	$6.47M	Sep 15, 2021	6.30M	Purchase	—	Sep 13	View
From 4	0.34	587.00K	$15.47	$9.08M	Jul 06, 2021	5.91M	Purchase	—	Jul 01 - 06	View
From 4	0.08	123.35K	$15.94	$1.97M	May 25, 2021	5.32M	Purchase	—	May 21 - 24	View
From 4	0.15	208.47K	$16.59	$3.46M	May 20, 2021	5.20M	Purchase	—	May 18 - 19	View
From 4	0.04	58.00K	$14.26	$827.17K	May 17, 2021	4.99M	Purchase	—	May 13	View
From 4/A	5.22	1.13M	$16.86	$19.10M	May 17, 2021	1.35M	Purchase	—	Apr 23 - 26	View
From 4	0.30	1.13M	$16.86	—	Apr 27, 2021	4.93M	Options	—	Apr 23 - 26	View
From 3	—	—	—	—	Apr 27, 2021	—	—	—	—	View

PVLApalvella therapeutics, inc.

Updated: Dec 17, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	1.73	438.93K	—	—	Dec 17, 2024	708.42K	Acquisition	—	Dec 13	View
From 3	—	—	—	—	May 22, 2023	20.33M	—	—	—	View
From 4	-0.01	50.00K	$4.50	-$224.97K	Sep 10, 2019	7.31M	Sale	—	Sep 06	View
From 3	—	—	—	—	Sep 10, 2019	4.98M	—	—	—	View
From 4	-0.72	5.00M	—	—	Feb 01, 2019	4.27M	Disposition	—	Jan 30	View
From 3	—	—	—	—	Nov 26, 2018	6.89M	—	—	—	View

ELDNeledon pharmaceuticals, inc.

Updated: Oct 31, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.49	4.75M	$3.65	$17.35M	Oct 31, 2024	27.25M	Purchase	—	Oct 29	View
From 4	1.83	7.86M	—	—	May 13, 2024	22.50M	Purchase	—	May 09	View
From 4	5.01	11.57M	—	—	May 09, 2023	14.64M	Purchase	—	May 05	View
From 3	—	—	—	—	Jan 31, 2022	2.31M	—	—	—	View
From 4	4.01	1.27M	—	—	Dec 28, 2020	1.74M	Options	—	Dec 22	View
From 3	—	—	—	—	Oct 05, 2020	193.93K	—	—	—	View

FDMT4d molecular therapeutics, inc.

Updated: Nov 13, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Nov 13, 2024	7.26M	Acq/Dis	—	Nov 08	View
From 3	—	—	—	—	Aug 01, 2024	7.26M	—	—	—	View
From 3	—	—	—	—	Jun 27, 2022	3.91M	—	—	—	View

THRDthird harmonic bio, inc.

Updated: Oct 31, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.23	1.00M	$14.30	-$14.30M	Oct 31, 2024	3.34M	Sale	—	Oct 29	View
From 4	0.05	214.06K	$4.11	$879.50K	Dec 22, 2022	4.34M	Purchase	—	Dec 20	View
From 3	—	—	—	—	Dec 22, 2022	4.12M	—	—	—	View

CGEMcullinan oncology, inc.

Updated: Jan 19, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.78	5.76M	—	—	Jan 19, 2023	1.66M	Disposition	—	Jan 19	View
From 4	0.11	751.40K	$11.00	$8.26M	Jun 03, 2022	7.42M	Purchase	—	Jun 01	View
From 4	0.20	1.11M	$9.09	$10.06M	May 16, 2022	6.66M	Purchase	—	May 12 - 13	View
From 4	0.06	276.00K	$10.75	$2.97M	Apr 05, 2022	5.55M	Purchase	—	Apr 01	View
From 3	—	—	—	—	Jan 10, 2022	5.28M	—	—	—	View

cti biopharma corp

Updated: Jun 28, 2023

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	9.33M	$9.10	-$80.59M	Jun 28, 2023	—	Disposition	—	Jun 26	View
From 4	—	80.00K	—	—	Apr 07, 2023	9.33M	Grant	—	Apr 05	View
From 4	-0.01	129.24K	$6.12	-$52.02M	Aug 11, 2022	9.25M	Sale	—	Aug 09	View
From 4	—	80.00K	—	—	Mar 11, 2022	9.38M	Grant	—	Mar 09	View
From 4	0.36	2.00M	$275.90	$5.08M	Apr 05, 2021	9.30M	Purchase	—	Apr 01	View
From 4	—	80.00K	—	—	Mar 12, 2021	7.30M	Grant	—	Mar 10	View
From 4	0.85	1.92K	—	—	Mar 04, 2020	6.95M	Purchase	—	Mar 02 - 04	View
From 4	-0.19	1.65M	$3.00	$19.00M	Feb 12, 2018	6.94M	Disposition	—	Feb 09	View
From 4	0.92	4.12M	—	—	Jun 14, 2017	8.60M	Purchase	—	Jun 09	View
From 4	0.01	1.00M	$1.22	$1.22M	Jan 11, 2016	72.02M	Purchase	—	Jan 07 - 08	View
From 3	—	—	—	—	Dec 14, 2015	43.80M	—	—	—	View

GPCRstructure therapeutics inc.

Updated: May 12, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	May 12, 2023	12.58M	Acq/Dis	—	May 10	View
From 3	—	—	—	—	Feb 13, 2023	12.58M	—	—	—	View

ENGNengene holdings inc.

Updated: Nov 13, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Nov 13, 2023	2.22M	—	—	—	View

PNTpoint biopharma global inc.

Updated: Dec 20, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	17.16M	$12.45	-$213.66M	Dec 20, 2023	—	Sale	—	Dec 18	View
From 3	—	—	—	—	Nov 06, 2023	17.16M	—	—	—	View

VSTMverastem, inc.

Updated: Feb 07, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Feb 07, 2022	19.63M	—	—	—	View

MRUSmerus n.v.

Updated: Oct 08, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.23	1.13M	$27.56	-$31.22M	Oct 08, 2021	3.84M	Sale	—	Oct 07 - 08	View
From 4	-0.31	2.19M	$20.75	-$45.36M	Jul 07, 2021	4.97M	Sale	—	Jul 02	View
From 4	0.04	300.00K	$19.75	$5.93M	Apr 01, 2021	7.16M	Purchase	—	Mar 30	View
From 4	0.02	79.50K	$22.75	$1.81M	Mar 24, 2021	6.86M	Purchase	—	Mar 22	View
From 4	0.04	250.00K	$23.00	$5.75M	Mar 18, 2021	6.78M	Purchase	—	Mar 16	View
From 4	0.15	844.68K	$24.75	$20.91M	Jan 25, 2021	6.53M	Purchase	—	Jan 21	View
From 4	0.03	160.00K	$16.05	$2.57M	Dec 22, 2020	5.68M	Purchase	—	Dec 18	View
From 4	0.03	146.75K	$11.75	$1.72M	Sep 17, 2020	5.52M	Purchase	—	Sep 15	View
From 4	0.04	189.65K	$11.10	$2.10M	Sep 14, 2020	5.38M	Purchase	—	Sep 10	View
From 4	0.04	201.91K	$11.17	$2.26M	Sep 08, 2020	5.19M	Purchase	—	Sep 03	View
From 4	0.02	87.25K	$15.20	$1.33M	Jun 10, 2020	4.99M	Purchase	—	Jun 08	View
From 4	0.43	1.46M	$14.00	$20.48M	Jun 03, 2020	4.90M	Purchase	—	Jun 01	View
From 4	0.09	278.73K	$16.15	$4.50M	Jan 21, 2020	3.44M	Purchase	—	Jan 16	View
From 4	0.03	83.96K	$14.98	$1.26M	Jan 15, 2020	3.16M	Purchase	—	Jan 13	View
From 3	—	—	—	—	Jan 13, 2020	3.07M	—	—	—	View

IDYAideaya biosciences, inc.

Updated: Feb 04, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.01	46.41K	$18.00	-$835.36K	Feb 04, 2021	3.06M	Sale	—	Feb 02	View
From 4	0.00	2.53K	$13.32	$33.70K	Jul 02, 2020	3.11M	Purchase	—	Jun 30	View
From 4	0.02	118.00K	$14.16	$1.69M	Jun 22, 2020	6.19M	Purchase	—	Jun 19 - 22	View
From 3	—	—	—	—	Jun 22, 2020	2.99M	—	—	—	View

CTMXcytomx therapeutics, inc.

Updated: Feb 18, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Feb 18, 2021	5.47M	—	—	—	View
From 3	—	—	—	—	Dec 28, 2020	5.47M	—	—	—	View

INFIQinfinity pharmaceuticals, inc.

Updated: Feb 19, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Feb 19, 2021	8.26M	—	—	—	View
From 4	-0.21	2.26M	$5.37	-$12.13M	Feb 16, 2021	8.26M	Sale	—	Feb 11	View
From 4	-0.36	5.85M	$4.14	-$24.21M	Jan 26, 2021	10.52M	Sale	—	Jan 22	View
From 4	0.01	175.00K	$1.20	$209.91K	Dec 17, 2018	16.37M	Purchase	—	Dec 13	View
From 4	0.02	100.00K	$1.30	$130.00K	Nov 30, 2018	16.20M	Purchase	—	Nov 28	View
From 4	0.04	1.47M	$1.36	$2.01M	Nov 21, 2018	41.78M	Purchase	—	Nov 19 - 21	View
From 4	0.02	905.93K	$1.35	$1.22M	Nov 15, 2018	41.15M	Purchase	—	Nov 13 - 15	View
From 4	0.17	3.94M	$1.65	$6.50M	Jun 21, 2018	27.02M	Purchase	—	Jun 19 - 21	View
From 4	0.09	1.51M	$1.95	$2.97M	Apr 11, 2018	18.55M	Purchase	—	Apr 09 - 10	View
From 4	0.11	1.60M	$1.26	$2.01M	Oct 05, 2017	15.88M	Purchase	—	Oct 03 - 04	View
From 4	0.00	4.38K	$1.34	$5.87K	Jan 05, 2017	6.67M	Purchase	—	Jan 03	View
From 4	0.06	742.40K	$1.34	$991.57K	Dec 30, 2016	12.63M	Purchase	—	Dec 28 - 30	View
From 4	0.04	654.92K	$1.33	$855.49K	Dec 20, 2016	17.52M	Purchase	—	Dec 16 - 20	View
From 4	0.02	201.39K	$1.19	$238.85K	Dec 02, 2016	10.48M	Purchase	—	Dec 01 - 02	View
From 3	—	—	—	—	Dec 02, 2016	5.07M	—	—	—	View

five prime therapeutics, inc.

Updated: Mar 08, 2021

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Mar 08, 2021	6.26M	—	—	—	View
From 4	-0.86	7.39M	$20.19	-$149.25M	Nov 13, 2020	1.24M	Sale	—	Nov 11	View
From 4	0.05	446.56K	$4.89	$2.18M	Nov 06, 2020	8.63M	Purchase	—	Nov 04 - 06	View
From 4	0.04	345.24K	$5.04	$1.74M	Oct 08, 2020	8.18M	Purchase	—	Oct 06	View
From 4	0.00	32.00	$3.80	$121.56	Sep 24, 2020	7.84M	Purchase	—	Sep 22	View
From 4	0.04	293.59K	$4.10	$1.20M	May 18, 2020	7.84M	Purchase	—	May 14	View
From 4	0.07	515.02K	$4.05	$2.09M	Dec 26, 2019	7.55M	Purchase	—	Dec 20	View
From 4	0.02	135.00K	$4.02	$542.36K	Dec 11, 2019	7.03M	Purchase	—	Dec 09	View
From 4	0.19	1.12M	$3.40	$3.81M	Nov 26, 2019	6.90M	Purchase	—	Nov 22	View
From 4	0.20	968.11K	$4.00	$3.87M	Nov 07, 2019	5.78M	Purchase	—	Nov 05	View
From 4	0.00	29.31K	$3.88	$113.81K	Oct 31, 2019	14.39M	Purchase	—	Oct 29 - 31	View
From 4	0.02	169.37K	$3.75	$634.32K	Oct 25, 2019	9.53M	Purchase	—	Oct 23 - 25	View
From 4	0.05	601.48K	$3.72	$2.25M	Oct 08, 2019	13.18M	Purchase	—	Oct 04 - 08	View
From 3	—	—	—	—	Oct 02, 2019	4.01M	—	—	—	View

CYTKcytokinetics inc

Updated: Dec 11, 2020VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.06	430.95K	$18.00	-$7.76M	Dec 11, 2020	7.03M	Sale	—	Dec 09	View
From 3	—	—	—	—	Dec 04, 2020	7.47M	—	—	—	View
From 4	-1.00	1.38K	—	—	Nov 20, 2020	7.07M	Disposition	—	Nov 20	View
From 3	—	—	—	—	Nov 16, 2020	7.07M	—	—	—	View
From 4	-0.15	1.07M	$15.79	-$16.92M	Feb 18, 2020	5.91M	Sale	—	Feb 13	View
From 4	0.03	342.07K	$9.46	$3.23M	Dec 12, 2019	13.84M	Purchase	—	Dec 10 - 11	View
From 3	—	—	—	—	Dec 12, 2019	6.64M	—	—	—	View

CALAcalithera biosciences, inc.

Updated: May 26, 2020VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.25	2.28M	$6.00	-$13.70M	May 26, 2020	6.96M	Sale	—	May 21	View
From 4	0.02	191.95K	$3.91	$750.85K	Nov 22, 2019	9.24M	Purchase	—	Nov 20	View
From 4	0.01	128.49K	$3.37	$433.00K	Nov 18, 2019	9.05M	Purchase	—	Nov 14	View
From 4	0.16	2.40M	$2.65	$6.31M	Oct 31, 2019	17.05M	Purchase	—	Oct 29 - 30	View
From 3	—	—	—	—	Jul 01, 2019	6.53M	—	—	—	View

principia biopharma inc.

Updated: Aug 20, 2020

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.05	2.27K	$35.79	$81.17K	Aug 20, 2020	51.20K	Purchase	—	Aug 18	View
From 3	—	—	—	—	Aug 20, 2020	—	—	—	—	View

concert pharmaceuticals, inc.

Updated: Jun 12, 2019

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.14	386.29K	$10.70	-$4.13M	Jun 12, 2019	2.30M	Sale	—	Jun 10	View
From 3	—	—	—	—	Apr 02, 2019	2.69M	—	—	—	View
From 4	-0.43	1.28M	$26.65	-$34.19M	Dec 21, 2017	1.71M	Sale	—	Dec 19	View
From 4	0.12	331.92K	$15.84	$5.26M	Oct 23, 2017	2.99M	Purchase	—	Oct 19	View
From 3	—	—	—	—	Sep 29, 2017	2.66M	—	—	—	View

immune design corp.

Updated: Dec 04, 2018

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.16	902.00K	$1.83	-$1.65M	Dec 04, 2018	4.82M	Sale	—	Dec 04	View
From 3	—	—	—	—	Nov 09, 2018	5.72M	—	—	—	View

SNDXsyndax pharmaceuticals inc

Updated: Jun 20, 2018VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Jun 20, 2018	2.90M	Acq/Dis	—	Jun 18	View
From 3	—	—	—	—	Dec 08, 2017	2.90M	—	—	—	View

arqule inc

Updated: Jun 01, 2018

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.11	1.04M	$5.00	-$5.18M	Jun 01, 2018	10.86M	Sale	—	May 30	View
From 4	-0.19	2.23M	$3.10	-$6.91M	Apr 20, 2018	11.90M	Sale	—	Apr 18	View
From 4	-0.16	2.30M	$2.90	-$6.67M	Apr 06, 2018	14.13M	Sale	—	Apr 04	View
From 3	—	—	—	—	Oct 20, 2017	14.21M	—	—	—	View
From 4	-0.13	603.00K	$6.13	-$3.70M	Apr 07, 2010	16.83M	Sale	—	Apr 05	View
From 4	-0.44	3.75M	$6.11	-$22.94M	Apr 02, 2010	19.24M	Sale	—	Mar 31 - 01	View
From 4	-0.30	3.68M	$5.25	-$19.32M	Sep 21, 2009	34.26M	Sale	—	Sep 17	View
From 4	0.03	340.90K	$2.40	$816.52K	Nov 25, 2008	12.24M	Purchase	—	Nov 21	View
From 4	0.03	294.41K	$2.65	$780.19K	Nov 21, 2008	11.90M	Purchase	—	Nov 19	View
From 4	0.22	2.13M	$2.35	$5.00M	Nov 13, 2008	11.61M	Purchase	—	Nov 10 - 12	View
From 4	0.17	1.36M	$3.90	$5.32M	Mar 11, 2008	9.48M	Purchase	—	Mar 10	View
From 4	0.00	8.20K	$4.75	$38.95K	Feb 26, 2008	8.12M	Purchase	—	Feb 22	View
From 4	0.02	186.00K	$4.95	$920.90K	Feb 25, 2008	8.11M	Purchase	—	Feb 21	View
From 4	0.00	28.10K	$5.05	$141.91K	Feb 22, 2008	7.92M	Purchase	—	Feb 20	View
From 4	0.01	81.90K	$5.09	$416.78K	Feb 20, 2008	7.90M	Purchase	—	Feb 15 - 19	View
From 4	0.01	83.70K	$4.96	$414.85K	Feb 13, 2008	7.81M	Purchase	—	Feb 11	View
From 4	0.03	259.00K	$4.98	$1.29M	Feb 12, 2008	7.73M	Purchase	—	Feb 08	View
From 4	0.05	368.30K	$4.90	$1.80M	Feb 11, 2008	7.47M	Purchase	—	Feb 07	View
From 4	0.03	375.10K	$5.06	$1.89M	Feb 05, 2008	14.08M	Purchase	—	Feb 01 - 04	View
From 4	0.08	510.00K	$4.71	$2.40M	Feb 04, 2008	6.73M	Purchase	—	Jan 31	View
From 4	0.01	154.60K	$4.47	$690.97K	Jan 25, 2008	18.45M	Purchase	—	Jan 23	View
From 4	0.02	107.30K	$4.65	$498.66K	Jan 16, 2008	6.06M	Purchase	—	Jan 15	View
From 4	0.00	24.80K	$4.50	$111.60K	Jan 16, 2008	5.96M	Purchase	—	Jan 14	View
From 4	0.06	324.23K	$4.37	$1.42M	Jan 14, 2008	5.93M	Purchase	—	Jan 10	View
From 3	—	—	—	—	Jan 11, 2008	17.79M	—	—	—	View
From 4	0.02	122.70K	$4.29	$525.97K	Jan 11, 2008	5.61M	Purchase	—	Jan 09	View
From 4	—	—	—	—	Jul 21, 2003	—	—	—	—	View

capstone therapeutics corp.

Updated: Jul 18, 2017

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.66	4.34M	$0.06	-$260.50K	Jul 18, 2017	2.27M	Sale	—	Jul 14	View
From 4	-0.13	616.56K	$0.30	-$184.97K	Jul 03, 2014	6.61M	Disposition	—	Jul 01	View
From 4	0.05	312.90K	$0.26	$81.04K	Sep 08, 2011	7.23M	Purchase	—	Sep 06	View
From 4	0.00	78.90K	$0.26	$20.51K	Aug 22, 2011	18.20M	Purchase	—	Aug 18 - 22	View
From 4	0.09	954.25K	$0.25	$238.56K	Aug 01, 2011	11.91M	Purchase	—	Jul 28 - 29	View
From 4	0.00	18.40K	$0.25	$4.60K	Jul 28, 2011	5.05M	Purchase	—	Jul 26	View
From 4	0.05	252.60K	$0.25	$63.10K	Jul 22, 2011	5.03M	Purchase	—	Jul 20	View
From 4	0.05	358.60K	$0.25	$89.34K	Jul 18, 2011	7.99M	Purchase	—	Jul 14 - 18	View
From 4	0.00	9.00K	$0.25	$2.25K	Jul 13, 2011	3.19M	Purchase	—	Jul 11	View
From 4	0.00	4.70K	$0.25	$1.17K	Jul 05, 2011	5.24M	Purchase	—	Jun 30	View
From 4	0.02	100.05K	$0.25	$24.99K	Jun 29, 2011	5.24M	Purchase	—	Jun 27 - 29	View
From 4	0.30	1.19M	$0.62	$736.47K	Oct 15, 2008	5.14M	Purchase	—	Oct 10 - 14	View
From 3	—	—	—	—	Oct 10, 2008	11.85M	—	—	—	View

XENExenon pharmaceuticals inc.

Updated: Jun 30, 2017VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4/A	0.03	85.46K	$3.04	$259.47K	Jun 30, 2017	2.99M	Purchase	—	Jun 27	View
From 3	—	—	—	—	Sep 12, 2016	2.50M	—	—	—	View

ALPNnivalis therapeutics, inc.

Updated: Jun 22, 2017VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.01	17.81K	$2.25	$40.06K	Jun 22, 2017	2.03M	Purchase	—	Jun 20	View
From 4	0.02	72.65K	$2.29	$166.07K	Jun 07, 2017	3.98M	Purchase	—	Jun 05 - 07	View
From 4	0.01	47.00K	$2.28	$106.53K	Jun 01, 2017	3.85M	Purchase	—	May 30 - 31	View
From 4	0.01	78.86K	$2.30	$181.32K	May 19, 2017	5.62M	Purchase	—	May 17 - 19	View
From 4	0.02	109.03K	$2.33	$253.43K	May 11, 2017	5.36M	Purchase	—	May 09 - 11	View
From 3	—	—	—	—	May 11, 2017	1.70M	—	—	—	View

RGLSregulus therapeutics inc.

Updated: Nov 27, 2017VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Nov 27, 2017	11.11M	—	—	—	View

cascadian therapeutics, inc.

Updated: Jun 27, 2016

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	17.25K	$800.00	$13.80M	Jun 27, 2016	23.83M	Grant	—	Jun 23	View
From 3	—	—	—	—	Dec 22, 2015	18.80M	—	—	—	View
From 4	-0.41	4.00M	—	—	Feb 09, 2015	5.66M	Disposition	—	Feb 05	View
From 4	0.04	378.44K	$1.82	$688.68K	Dec 17, 2014	9.66M	Purchase	—	Dec 15 - 17	View
From 3	—	—	—	—	Dec 17, 2014	9.28M	—	—	—	View
From 4	-0.10	1.20M	$2.42	-$2.83M	Jul 16, 2014	10.44M	Disposition	—	Jul 16	View
From 4	0.02	129.00K	$1.78	$229.62K	Nov 05, 2013	7.48M	Purchase	—	Nov 01	View
From 4	0.04	258.36K	$1.65	$426.17K	Aug 12, 2013	7.35M	Purchase	—	Aug 08	View
From 4	0.05	338.09K	$1.76	$589.60K	Aug 02, 2013	7.09M	Purchase	—	Jul 31 - 01	View
From 4	0.01	214.47K	$1.79	$387.23K	Jun 07, 2013	19.95M	Purchase	—	Jun 05 - 07	View
From 3	—	—	—	—	Jun 07, 2013	7.84M	—	—	—	View

chemocentryx, inc.

Updated: Nov 05, 2015

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	2.74M	$7.00	-$2.52M	Nov 05, 2015	3.41M	Sale	—	Nov 03 - 05	View
From 4	-0.02	50.00K	$6.97	-$348.51K	Nov 02, 2015	6.16M	Sale	—	Nov 02	View
From 4	-0.25	955.70K	$9.00	-$8.60M	Jun 11, 2015	6.21M	Sale	—	Jun 09 - 10	View
From 4	0.03	189.80K	$5.01	$951.15K	Dec 05, 2013	10.45M	Purchase	—	Dec 03 - 05	View
From 4	0.02	136.07K	$4.84	$669.80K	Nov 06, 2013	11.29M	Purchase	—	Nov 04 - 06	View
From 4	0.04	336.23K	$4.98	$1.68M	Nov 01, 2013	12.75M	Purchase	—	Oct 30 - 01	View
From 4	0.31	1.29M	$5.31	$6.89M	Oct 10, 2013	9.17M	Purchase	—	Oct 08 - 09	View
From 4	0.08	109.42K	$5.49	$601.20K	Oct 07, 2013	5.21M	Purchase	—	Oct 03	View
From 4	0.14	325.63K	$6.02	$1.94M	Sep 13, 2013	6.45M	Purchase	—	Sep 11 - 13	View
From 4/A	0.01	40.00K	$12.00	$479.83K	Nov 19, 2012	4.78M	Purchase	—	Nov 06	View
From 4	0.01	40.00K	$12.00	$479.83K	Nov 08, 2012	3.75M	Purchase	—	Nov 06	View
From 3	—	—	—	—	Aug 31, 2012	4.74M	—	—	—	View

GYREcatalyst biosciences, inc.

Updated: Aug 21, 2015VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Aug 21, 2015	881.67K	—	—	—	View
From 4/A	0.15	595.00K	$4.00	$2.38M	Nov 20, 2012	5.04M	Purchase	—	Nov 16	View
From 4	0.18	1.29M	$4.56	$5.24M	Nov 19, 2012	8.62M	Purchase	—	Nov 14 - 16	View
From 4	0.01	72.43K	$4.05	$291.93K	Nov 09, 2012	5.71M	Purchase	—	Nov 07 - 08	View
From 4	0.02	139.70K	$4.05	$566.18K	Nov 02, 2012	8.28M	Purchase	—	Oct 31 - 02	View
From 3	—	—	—	—	Sep 10, 2012	3.02M	—	—	—	View
From 4	-0.24	638.40K	$23.60	-$15.06M	Oct 20, 2009	8.25M	Sale	—	Oct 16	View
From 4	0.00	9.52K	$2.99	$28.49K	Jul 16, 2009	10.80M	Purchase	—	Jul 14	View
From 4	0.01	25.70K	$3.06	$78.58K	Jul 13, 2009	10.76M	Purchase	—	Jul 09 - 13	View
From 3	—	—	—	—	Jul 13, 2009	2.67M	—	—	—	View

PTNpalatin technologies inc

Updated: Mar 03, 2014VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.07	293.82K	$1.09	-$320.27K	Mar 03, 2014	3.71M	Sale	—	Feb 27	View
From 4	-0.12	540.18K	$1.14	-$615.88K	Feb 26, 2014	4.00M	Sale	—	Feb 24 - 26	View
From 4	-0.06	305.97K	$1.15	-$357.06K	Feb 19, 2014	4.54M	Sale	—	Feb 14 - 19	View
From 3	—	—	—	—	Oct 07, 2011	4.85M	—	—	—	View

regado biosciences inc

Updated: Feb 10, 2014

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Feb 10, 2014	3.10M	—	—	—	View

array biopharma inc

Updated: Jul 10, 2014

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.07	494.09K	$4.56	-$2.25M	Jul 10, 2014	12.47M	Disposition	—	Jul 01	View
From 3	—	—	—	—	Jul 03, 2014	12.97M	—	—	—	View
From 3	—	—	—	—	Nov 19, 2012	11.14M	—	—	—	View
From 4	0.01	183.85K	$2.12	$388.55K	Dec 05, 2011	30.48M	Purchase	—	Nov 23 - 05	View
From 3	—	—	—	—	Nov 04, 2011	7.48M	—	—	—	View
From 4	-1.00	3.87M	$5.00	-$19.33M	Nov 07, 2003	—	Sale	—	Nov 05	View

RIGLrigel pharmaceuticals inc

Updated: Nov 20, 2013VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.21	484.62K	$2.64	-$1.28M	Nov 20, 2013	8.73M	Sale	—	Nov 19	View
From 4	0.01	32.70K	$3.47	$113.39K	Jun 11, 2013	9.22M	Purchase	—	Jun 07	View
From 3	—	—	—	—	May 15, 2013	9.70M	—	—	—	View

NBIXneurocrine biosciences inc

Updated: Feb 10, 2012VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Feb 10, 2012	5.52M	—	—	—	View
From 4	0.01	29.50K	$5.96	$175.67K	Oct 14, 2011	5.52M	Purchase	—	Oct 12	View
From 4	0.01	73.90K	$5.59	$413.48K	Oct 12, 2011	5.49M	Purchase	—	Oct 10 - 11	View
From 3	—	—	—	—	Oct 12, 2011	5.42M	—	—	—	View
From 4	-0.04	198.00K	$2.78	-$550.69K	Apr 13, 2010	20.17M	Sale	—	Apr 09 - 12	View
From 4	-0.02	105.00K	$2.70	-$283.55K	Apr 01, 2010	20.96M	Sale	—	Mar 30 - 31	View
From 4	-0.07	413.10K	$2.70	-$1.12M	Mar 29, 2010	21.38M	Sale	—	Mar 25 - 29	View
From 4	-0.03	189.00K	$2.76	-$521.48K	Mar 24, 2010	23.03M	Sale	—	Mar 22 - 24	View
From 4	0.00	15.90K	$3.10	$49.27K	Jan 26, 2009	5.95M	Purchase	—	Jan 22 - 23	View
From 4	0.02	100.20K	$3.08	$308.23K	Jan 22, 2009	5.93M	Purchase	—	Jan 20 - 21	View
From 4	0.00	7.40K	$3.05	$22.59K	Jan 20, 2009	5.83M	Purchase	—	Jan 15	View
From 4	0.00	10.60K	$2.80	$29.68K	Jan 02, 2009	5.82M	Purchase	—	Dec 30	View
From 4	0.02	99.40K	$2.35	$233.17K	Dec 03, 2008	5.81M	Purchase	—	Dec 01	View
From 4	0.01	54.40K	$2.45	$133.26K	Nov 26, 2008	5.71M	Purchase	—	Nov 24	View
From 4	0.09	447.05K	$2.72	$1.22M	Oct 15, 2008	5.66M	Purchase	—	Oct 10	View
From 4	0.01	119.10K	$4.25	$505.17K	Jul 09, 2008	10.79M	Purchase	—	Jul 07 - 08	View
From 4	0.01	37.70K	$4.17	$157.13K	Jul 07, 2008	5.09M	Purchase	—	Jul 02 - 03	View
From 4	0.01	27.10K	$4.72	$127.87K	May 29, 2008	5.05M	Purchase	—	May 27 - 28	View
From 4	0.03	152.60K	$4.63	$706.81K	May 19, 2008	5.03M	Purchase	—	May 15 - 16	View
From 4	0.01	43.60K	$5.00	$218.00K	Mar 24, 2008	4.88M	Purchase	—	Mar 20	View
From 4	0.03	153.00K	$4.96	$759.11K	Mar 19, 2008	4.83M	Purchase	—	Mar 18	View
From 4	0.00	23.90K	$4.92	$117.53K	Mar 17, 2008	9.34M	Purchase	—	Mar 13	View
From 4	0.03	156.60K	$4.91	$768.27K	Mar 13, 2008	4.65M	Purchase	—	Mar 11 - 12	View
From 4	0.08	329.60K	$4.92	$1.62M	Mar 11, 2008	4.50M	Purchase	—	Mar 07 - 10	View
From 4	0.02	86.70K	$5.00	$433.16K	Mar 10, 2008	4.17M	Purchase	—	Mar 06	View
From 4	0.03	121.20K	$4.94	$598.43K	Mar 05, 2008	4.08M	Purchase	—	Mar 03 - 04	View
From 3	—	—	—	—	Mar 03, 2008	10.73M	—	—	—	View
From 4	0.02	70.40K	$5.00	$351.71K	Mar 03, 2008	3.96M	Purchase	—	Feb 28 - 29	View
From 4	0.01	20.80K	$5.00	$103.98K	Feb 28, 2008	3.89M	Purchase	—	Feb 26	View
From 4	0.06	187.00K	$4.91	$917.52K	Feb 26, 2008	3.53M	Purchase	—	Feb 22 - 25	View
From 4	0.03	106.00K	$4.70	$498.58K	Feb 25, 2008	3.34M	Purchase	—	Feb 21	View

LGNDligand pharmaceuticals inc

Updated: Nov 19, 2012VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4/A	0.02	16.59K	$15.19	$252.02K	Nov 19, 2012	3.25M	Purchase	—	Oct 26 - 31	View
From 3	—	—	—	—	Jul 06, 2011	1.97M	—	—	—	View
From 3	—	—	—	—	Nov 07, 2008	29.32M	—	—	—	View

kent international holdings inc

Updated: Dec 28, 2011

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	725.61K	$2.50	-$1.81M	Dec 28, 2011	—	Disposition	—	Dec 23	View

icagen inc

Updated: Sep 09, 2011

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.15	126.70K	$6.00	$760.71K	Sep 09, 2011	980.20K	Purchase	—	Sep 07	View
From 3	—	—	—	—	Sep 09, 2011	853.50K	—	—	—	View

celera corp

Updated: May 17, 2011

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.02	290.75K	$8.03	$2.33M	May 17, 2011	76.51M	Purchase	—	May 13 - 17	View
From 4	0.20	3.08M	$8.03	$24.71M	May 12, 2011	75.35M	Purchase	—	May 10 - 12	View
From 4	0.11	1.58M	$8.05	$12.68M	May 10, 2011	63.04M	Purchase	—	May 06 - 09	View
From 4	0.23	2.68M	$8.05	$21.58M	May 06, 2011	56.74M	Purchase	—	May 04 - 05	View
From 4	0.09	981.60K	$8.00	$7.85M	Apr 22, 2011	45.98M	Purchase	—	Apr 20 - 21	View
From 4	0.02	186.20K	$8.07	$1.50M	Apr 19, 2011	42.05M	Purchase	—	Apr 15 - 19	View
From 4	0.02	215.00K	$8.05	$1.73M	Apr 14, 2011	41.30M	Purchase	—	Apr 12 - 14	View
From 4	0.07	640.63K	$8.15	$5.22M	Apr 11, 2011	40.44M	Purchase	—	Apr 07 - 11	View
From 4	0.02	182.00K	$8.21	$1.49M	Apr 07, 2011	37.88M	Purchase	—	Apr 05 - 06	View
From 3	—	—	—	—	Mar 23, 2011	9.29M	—	—	—	View

supergen inc

Updated: Apr 21, 2010

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.03	170.00K	$3.56	-$604.35K	Apr 21, 2010	22.33M	Sale	—	Apr 19 - 20	View
From 4	-0.00	4.30K	$2.69	-$11.57K	May 13, 2008	5.75M	Sale	—	May 09	View
From 4	-0.00	7.99K	$2.72	-$21.73K	May 08, 2008	5.76M	Sale	—	May 06 - 07	View
From 4	-0.02	107.21K	$2.84	-$303.99K	May 05, 2008	5.77M	Sale	—	May 01 - 02	View
From 3	—	—	—	—	Mar 20, 2008	17.62M	—	—	—	View

facet biotech corp

Updated: Feb 09, 2010

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.01	39.20K	$15.48	$606.62K	Feb 09, 2010	15.76M	Purchase	—	Feb 05 - 09	View
From 4	0.04	156.75K	$15.67	$2.46M	Feb 04, 2010	15.60M	Purchase	—	Feb 02 - 04	View
From 4	0.08	271.60K	$15.69	$4.26M	Jan 29, 2010	14.98M	Purchase	—	Jan 27 - 29	View
From 3	—	—	—	—	Sep 10, 2009	3.47M	—	—	—	View

DVAXdynavax technologies corp

Updated: Sep 11, 2009VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.22	1.21M	$2.76	-$3.35M	Sep 11, 2009	17.12M	Sale	—	Sep 10	View
From 4	-0.07	399.50K	$2.00	-$800.73K	Aug 10, 2009	21.96M	Sale	—	Aug 05 - 06	View
From 4	-0.00	15.60K	$1.85	-$28.91K	Aug 03, 2009	23.56M	Sale	—	Jul 30	View
From 4	-0.06	407.60K	$1.94	-$789.23K	Jul 29, 2009	23.62M	Sale	—	Jul 27 - 29	View
From 4	-0.22	1.80M	$1.90	-$3.41M	Jun 05, 2009	25.25M	Sale	—	Jun 03 - 04	View
From 4	-0.00	22.00K	$1.30	-$28.60K	May 01, 2009	8.11M	Sale	—	Apr 27	View
From 3	—	—	—	—	Oct 24, 2008	24.40M	—	—	—	View

RGENrepligen corp

Updated: Jul 08, 2009VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.14	451.80K	$5.52	-$2.49M	Jul 08, 2009	11.06M	Sale	—	Jul 06 - 07	View
From 3	—	—	—	—	May 20, 2009	12.87M	—	—	—	View
From 4	—	—	—	—	May 20, 2003	—	—	—	—	View

CRIScuris inc

Updated: Apr 29, 2009VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.33	2.97M	$1.15	-$3.42M	Apr 29, 2009	5.95M	Sale	—	Apr 27	View
From 3	—	—	—	—	Feb 13, 2009	26.77M	—	—	—	View

MNOVmedicinova inc

Updated: Dec 24, 2009VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Dec 24, 2009	—	—	—	—	View

adolor corp

Updated: Sep 24, 2009

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.08	354.00K	$1.69	-$599.71K	Sep 24, 2009	16.49M	Sale	—	Sep 22	View
From 4	-0.08	402.00K	$1.67	-$671.74K	Sep 21, 2009	17.91M	Sale	—	Sep 17 - 21	View
From 4	-0.11	588.00K	$1.73	-$1.02M	Sep 16, 2009	19.52M	Sale	—	Sep 14 - 16	View
From 4	-0.12	725.50K	$1.67	-$1.21M	Jul 15, 2009	21.87M	Sale	—	Jul 13 - 14	View
From 4/A	-0.00	21.50K	$2.00	-$42.97K	Jun 23, 2009	24.77M	Sale	—	Jun 19	View
From 4	0.00	1.00K	$2.95	$2.95K	Nov 04, 2008	6.21M	Purchase	—	Oct 31	View
From 4	0.01	87.90K	$2.85	$250.30K	Oct 31, 2008	6.21M	Purchase	—	Oct 29 - 30	View
From 4	0.30	1.42M	$2.78	$3.94M	Oct 29, 2008	6.13M	Purchase	—	Oct 27 - 28	View
From 4	0.05	203.70K	$3.23	$657.47K	Oct 24, 2008	4.71M	Purchase	—	Oct 22 - 23	View
From 4	0.02	69.90K	$3.09	$215.90K	Oct 17, 2008	4.51M	Purchase	—	Oct 15 - 16	View
From 4	0.01	57.00K	$3.23	$184.08K	Oct 15, 2008	4.44M	Purchase	—	Oct 13 - 14	View
From 3	—	—	—	—	Oct 15, 2008	13.28M	—	—	—	View

combinatorx, inc

Updated: Dec 24, 2009

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.32	3.18M	$0.80	-$2.54M	Dec 24, 2009	27.32M	Sale	—	Dec 22	View
From 4	0.18	1.53M	$0.57	$872.42K	Dec 09, 2008	10.01M	Purchase	—	Dec 05	View
From 4	0.00	23.70K	$0.54	$12.88K	Dec 05, 2008	8.48M	Purchase	—	Dec 03 - 04	View
From 4	0.00	36.60K	$0.55	$20.10K	Dec 03, 2008	8.45M	Purchase	—	Dec 01 - 02	View
From 4	0.00	6.60K	$0.49	$3.26K	Dec 01, 2008	8.42M	Purchase	—	Nov 26	View
From 4	0.00	12.30K	$0.47	$5.75K	Nov 26, 2008	8.41M	Purchase	—	Nov 25	View
From 4	0.01	95.10K	$0.45	$42.80K	Nov 25, 2008	8.40M	Purchase	—	Nov 21 - 24	View
From 4	0.00	9.20K	$0.60	$5.49K	Nov 18, 2008	8.30M	Purchase	—	Nov 14	View
From 4	0.00	12.60K	$0.60	$7.56K	Nov 14, 2008	8.29M	Purchase	—	Nov 12 - 13	View
From 4	0.03	262.80K	$0.59	$154.61K	Nov 12, 2008	8.28M	Purchase	—	Nov 07 - 11	View
From 4	0.02	191.60K	$0.60	$114.77K	Nov 07, 2008	8.02M	Purchase	—	Nov 05 - 06	View
From 4	0.54	2.74M	$0.65	$1.78M	Oct 17, 2008	7.83M	Purchase	—	Oct 15 - 16	View
From 4	0.02	83.80K	$0.61	$51.44K	Oct 15, 2008	5.08M	Purchase	—	Oct 10 - 13	View
From 3	—	—	—	—	Oct 09, 2008	12.32M	—	—	—	View
From 4	0.22	893.10K	$0.65	$581.83K	Oct 09, 2008	5.00M	Purchase	—	Oct 07 - 08	View

inhibitex, inc.

Updated: Jan 09, 2009

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Jan 09, 2009	16.93M	—	—	—	View

neurobiological technologies inc /ca/

Updated: Oct 23, 2009

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.93	4.61M	$0.91	-$4.19M	Oct 23, 2009	1.33M	Sale	—	Oct 21	View
From 4	0.01	47.00K	$2.43	$114.08K	Jun 26, 2008	4.94M	Purchase	—	Nov 06	View
From 3/A	—	—	—	—	Jun 26, 2008	14.67M	—	—	—	View
From 3	—	—	—	—	Nov 02, 2007	14.73M	—	—	—	View

avigen inc \de

Updated: Nov 20, 2009

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.00	626.00	$1.50	-$939.00	Nov 20, 2009	31.35M	Sale	—	Nov 18	View
From 4	-0.06	472.20K	$1.50	-$708.30K	Oct 23, 2009	31.35M	Sale	—	Oct 21	View
From 4	0.02	158.30K	$0.74	$116.85K	Nov 20, 2008	8.31M	Purchase	—	Nov 18 - 19	View
From 4	0.00	26.50K	$0.75	$19.82K	Nov 17, 2008	8.24M	Purchase	—	Nov 13	View
From 4	0.01	302.60K	$0.73	$223.42K	Nov 13, 2008	24.21M	Purchase	—	Nov 10 - 12	View
From 4	0.01	302.60K	$0.73	$223.42K	Nov 13, 2008	24.21M	Purchase	—	Nov 10 - 12	View
From 4	0.02	127.50K	$0.71	$91.03K	Nov 10, 2008	7.91M	Purchase	—	Nov 06 - 07	View
From 4	0.01	53.30K	$0.74	$39.26K	Nov 06, 2008	7.78M	Purchase	—	Nov 04	View
From 3	—	—	—	—	Oct 22, 2008	23.19M	—	—	—	View

nps pharmaceuticals inc

Updated: Sep 23, 2008

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.10	474.80K	$8.65	-$4.11M	Sep 23, 2008	4.38M	Sale	—	Sep 19 - 22	View
From 4	0.00	3.40K	$3.90	$13.26K	Mar 20, 2008	4.86M	Purchase	—	Mar 19	View
From 4	0.01	45.50K	$3.80	$172.90K	Mar 19, 2008	4.85M	Purchase	—	Mar 17	View
From 4	0.02	108.30K	$3.84	$415.73K	Mar 17, 2008	4.81M	Purchase	—	Mar 13 - 14	View
From 4	0.02	92.50K	$3.76	$347.67K	Mar 13, 2008	4.70M	Purchase	—	Mar 11 - 12	View
From 3	—	—	—	—	Mar 11, 2008	13.01M	—	—	—	View
From 4	0.06	272.10K	$3.77	$1.03M	Mar 11, 2008	4.61M	Purchase	—	Mar 07 - 10	View

pharmacopeia inc

Updated: Nov 07, 2008

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.23	788.00K	$0.90	$709.20K	Nov 07, 2008	4.19M	Purchase	—	Nov 05	View
From 3	—	—	—	—	Oct 23, 2008	10.20M	—	—	—	View

sgx pharmaceuticals, inc.

Updated: Aug 27, 2008

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	5.51M	$3.00	-$16.52M	Aug 27, 2008	—	Disposition	—	Aug 20	View
From 4	0.31	1.30M	$3.04	$3.94M	Jul 11, 2008	5.51M	Purchase	—	Jul 08 - 11	View
From 4	0.36	1.11M	$1.45	$1.60M	Jun 20, 2008	4.21M	Purchase	—	Jun 18	View
From 3	—	—	—	—	Apr 14, 2008	9.31M	—	—	—	View
From 3	—	—	—	—	Feb 15, 2007	4.97M	—	—	—	View

viacell inc

Updated: Nov 26, 2007

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	7.31M	$7.25	-$52.97M	Nov 26, 2007	—	Sale	—	Nov 09	View
From 3	—	—	—	—	Oct 17, 2007	21.92M	—	—	—	View

advanced magnetics inc

Updated: Jan 13, 2006

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.23	289.97K	$15.56	-$4.51M	Jan 13, 2006	985.16K	Sale	—	Jan 13 - 13	View
From 4	-0.15	213.80K	$11.94	-$2.55M	Aug 15, 2005	1.22M	Sale	—	Aug 11	View
From 4	0.02	21.60K	$8.78	$189.59K	Aug 15, 2003	1.44M	Purchase	—	Aug 13	View
From 4	0.02	24.00K	$8.99	$215.76K	Jul 29, 2003	1.42M	Purchase	—	Jul 25	View

aeolus pharmaceuticals, inc.

Updated: Jun 08, 2006

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.18	356.50K	$0.50	$237.66K	Jun 08, 2006	2.32M	Options	—	Jun 06	View
From 3	—	—	—	—	Feb 13, 2006	2.28M	—	—	—	View

aerogen inc

Updated: Feb 01, 2005

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3/A	—	—	—	—	Feb 01, 2005	—	—	—	—	View
From 3	—	—	—	—	Jan 28, 2005	—	—	—	—	View

arena pharmaceuticals inc

Updated: Jul 09, 2004

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.12	828.09K	$5.10	-$4.22M	Jul 09, 2004	5.89M	Sale	—	Jul 07 - 08	View
From 4	-0.03	95.00K	$5.42	-$514.90K	Jul 06, 2004	2.74M	Sale	—	Jul 01	View
From 4	-0.02	71.00K	$5.31	-$376.80K	Jul 01, 2004	2.83M	Sale	—	Jun 29	View
From 4	-0.01	54.00K	$5.36	-$287.01K	Jun 29, 2004	5.82M	Sale	—	Jun 28	View
From 4	-0.00	6.00K	$5.52	-$33.11K	Jun 22, 2004	2.96M	Sale	—	Jun 18	View
From 4	-0.03	104.00K	$5.40	-$561.60K	Jun 18, 2004	2.97M	Sale	—	Jun 16	View
From 4	-0.02	144.50K	$6.00	-$867.00K	Jan 22, 2004	8.67M	Sale	—	Jan 20 - 21	View
From 4	-0.03	95.00K	$6.05	-$574.75K	Jan 16, 2004	3.21M	Sale	—	Jan 14	View
From 4	-0.01	24.00K	$6.30	-$151.20K	Jan 13, 2004	3.31M	Sale	—	Jan 09	View
From 4	-0.26	1.19M	$6.20	-$7.36M	Jan 05, 2004	3.33M	Sale	—	Dec 31	View
From 4	-0.39	2.91M	$7.69	-$22.39M	Oct 21, 2003	4.52M	Sale	—	Oct 17	View

zonagen inc

Updated: Feb 18, 2004

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Feb 18, 2004	1.67M	—	—	—	View

applied molecular evolution inc

Updated: Jan 12, 2004

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.21	822.90K	$17.80	-$14.65M	Jan 12, 2004	3.14M	Sale	—	Jan 08	View
From 4	-0.02	94.90K	$17.79	-$1.69M	Jan 08, 2004	4.75M	Sale	—	Jan 06	View
From 4	-0.12	665.00K	$17.79	-$11.84M	Jan 06, 2004	5.10M	Sale	—	Jan 02 - 05	View

neurogen corp

Updated: Aug 07, 2003

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.01	46.00K	$4.81	$221.84K	Aug 07, 2003	4.78M	Purchase	—	Aug 05	View
From 4	0.04	98.00K	$4.67	$457.63K	Aug 04, 2003	2.35M	Purchase	—	Jul 31	View
From 4	0.02	47.00K	$4.85	$227.95K	Jul 31, 2003	2.25M	Purchase	—	Jul 29	View
From 4	—	—	—	—	Jul 24, 2003	—	—	—	—	View
From 4	—	—	—	—	Jul 21, 2003	—	—	—	—	View
From 4	—	—	—	—	Jul 16, 2003	—	—	—	—	View
From 3	—	—	—	—	May 29, 2003	—	—	—	—	View

genaera corp

Updated: Sep 05, 2003

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.07	560.00K	$4.81	-$2.69M	Sep 05, 2003	7.43M	Sale	—	Aug 28 - 03	View
From 3	—	—	—	—	Jun 09, 2003	—	—	—	—	View

corvas international inc

Updated: Aug 06, 2003

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	3.01M	—	—	Aug 06, 2003	—	Disposition	—	Jul 30	View
From 4	-0.00	2.00K	$2.87	-$5.74K	Jul 31, 2003	2.38M	Sale	—	Jul 29	View
From 4	—	—	—	—	Jul 24, 2003	—	—	—	—	View
From 4	—	—	—	—	Jul 21, 2003	—	—	—	—	View
From 4	—	—	—	—	Jul 15, 2003	—	—	—	—	View
From 4	—	—	—	—	Jul 10, 2003	—	—	—	—	View

BCRXbiocryst pharmaceuticals inc

Updated: Oct 29, 2003VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.34	746.00K	$8.00	-$5.97M	Oct 29, 2003	1.46M	Sale	—	Oct 27	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions